PG
DSCI

PEAK6 Group’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

PEAK6 Group’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,100
Closed -$34K – 5267
2016
Q1 		$34K Sell
11,100
-1,000
-8% -$3.35K ﹤0.01% 4001
2015
Q4 		$55K Buy
12,100
+4,700
+64% +$22.3K ﹤0.01% 4250
2015
Q3 		$35K Buy
7,400
+5,300
+252% +$34.2K ﹤0.01% 4768
2015
Q2 		$15K Sell
2,100
-25,300
-92% -$190K ﹤0.01% 4847
2015
Q1 		$232K Sell
27,400
-4,400
-14% -$37.5K ﹤0.01% 3323
2014
Q4 		$296K Sell
31,800
-25,500
-45% -$222K ﹤0.01% 3040
2014
Q3 		$477K Buy
+57,300
New +$531K ﹤0.01% 2517

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PEAK6 Group's DSCI Position: Q2 2016 in Review

PEAK6 Group sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2016, closing a stake of 5,974 shares — an estimated $19K sold.

PEAK6 Group first reported a position in DSCI in Q1 2014 and held it in 7 quarters. The position peaked at $722K in Q1 2015. 53 funds tracked by Wall St. Rank hold DSCI as of Q2 2016.

  • PEAK6 Group reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 5,974 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2016, an estimated $19K.
  • PEAK6 Group first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 7 quarters.
  • PEAK6 Group's Derma Sciences, Inc. Common Stock (DE) position peaked at $722K in Q1 2015.
  • 53 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.